login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
THERIVA BIOLOGICS INC (TOVX) Stock News
USA
-
NYSE Arca
- NYSEARCA:TOVX -
US87164U5083
-
Common Stock
0.2059
USD
-0.01 (-5.94%)
Last: 12/2/2025, 8:11:22 PM
0.2097
USD
+0 (+1.85%)
After Hours:
12/2/2025, 8:11:22 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TOVX Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - By: Theriva Biologics, Inc.
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2025
20 days ago - By: Benzinga
- Mentions:
DERM
INTS
LPTX
CMND
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
21 days ago - By: Theriva Biologics, Inc.
Theriva™ Biologics Reports Third Quarter 2025 Operational Highlights and Financial Results
a month ago - By: Theriva Biologics, Inc.
Theriva Biologics Provides Response to Unusual Market Action
a month ago - By: Benzinga
- Mentions:
PMI
GNTA
AVR
USBC
...
12 Health Care Stocks Moving In Friday's Intraday Session
2 months ago - By: Theriva Biologics, Inc.
Theriva™ Biologics anuncia una operación de incentivo de warrants por un importe bruto de 4 millones de dólares
2 months ago - By: Theriva Biologics, Inc.
Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds
2 months ago - By: Theriva Biologics, Inc.
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
2 months ago - By: Theriva Biologics, Inc.
Theriva™ Biologics anuncia la presentación del VCN-12, un adenovirus oncolítico de nueva generación, en el 32.º Congreso Anual de la Sociedad Europea de Terapia Génica y Celular (ESGCT)
2 months ago - By: Theriva Biologics, Inc.
Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
4 months ago - By: Theriva Biologics, Inc.
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del segundo trimestre de 2025
4 months ago - By: Theriva Biologics, Inc.
Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results
Please enable JavaScript to continue using this application.